| P50 | author | Lishomwa Ndhlovu | Q74388390 |
| P2093 | author name string | Brooks I Mitchell | |
| | Elizabeth I Laws | |
| P2860 | cites work | Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART | Q58585537 |
| | Combination therapy with anti-HIV-1 antibodies maintains viral suppression | Q59090059 |
| | Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals | Q59351843 |
| | Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection | Q59359146 |
| | Phenotypic and functional characterization of human T cell clones | Q69841334 |
| | Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism | Q74457489 |
| | Macrophage HIV-1 infection in duodenal tissue of patients on long term HAART | Q84229162 |
| | CCR2 on Peripheral Blood CD14+CD16+ Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs? | Q89451196 |
| | A quantitative approach for measuring the reservoir of latent HIV-1 proviruses | Q91284113 |
| | HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy | Q91341307 |
| | Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism | Q24594703 |
| | Gene transfer in humans using a conditionally replicating lentiviral vector | Q24675343 |
| | Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1 | Q26781918 |
| | HIV-1 eradication strategies: design and assessment | Q26864933 |
| | TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection | Q27316403 |
| | Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection | Q27317216 |
| | CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cells | Q27322949 |
| | Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant | Q27323780 |
| | Semen CD4+ T cells and macrophages are productively infected at all stages of SIV infection in macaques | Q27331721 |
| | Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy | Q28253761 |
| | The neuropathogenesis of AIDS | Q28300983 |
| | Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans | Q28345408 |
| | Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy | Q28544949 |
| | Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation | Q29615068 |
| | Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases | Q29615069 |
| | Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy | Q29615992 |
| | Recovery of replication-competent HIV despite prolonged suppression of plasma viremia | Q29615995 |
| | Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA. | Q33178132 |
| | Bone-marrow-derived microglia: myth or reality? | Q33335604 |
| | Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia | Q33501775 |
| | Small alveolar macrophages are infected preferentially by HIV and exhibit impaired phagocytic function | Q33562292 |
| | HIV DNA in circulating monocytes as a mechanism to dementia and other HIV complications | Q33805298 |
| | RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. | Q34025414 |
| | HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat | Q34106191 |
| | Combination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1 | Q34132738 |
| | Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity | Q34204325 |
| | Disulfiram reactivates latent HIV-1 expression through depletion of the phosphatase and tensin homolog | Q34284559 |
| | Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy | Q34290545 |
| | Macrophages and their relevance in Human Immunodeficiency Virus Type I infection | Q34303855 |
| | Absence of detectable HIV-1 viremia after treatment cessation in an infant | Q34379777 |
| | Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques | Q34550643 |
| | Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay | Q34758220 |
| | Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts | Q35202038 |
| | The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection | Q35213775 |
| | Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapy. | Q35436367 |
| | Viremic relapse after HIV-1 remission in a perinatally infected child | Q35633017 |
| | The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo | Q35778783 |
| | The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency | Q35829282 |
| | The majority of freshly sorted simian immunodeficiency virus (SIV)-specific CD8(+) T cells cannot suppress viral replication in SIV-infected macrophages | Q35868086 |
| | Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-ĸB-dependent mechanism | Q35877276 |
| | A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals | Q36038655 |
| | Lysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D. | Q36064034 |
| | CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. | Q36077348 |
| | Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat | Q36086345 |
| | Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing | Q36086379 |
| | CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs | Q36250079 |
| | Activation and lysis of human CD4 cells latently infected with HIV-1 | Q36250921 |
| | Preferential Destruction of Interstitial Macrophages over Alveolar Macrophages as a Cause of Pulmonary Disease in Simian Immunodeficiency Virus-Infected Rhesus Macaques | Q36260388 |
| | Reduced basal transcriptional activity of central nervous system-derived HIV type 1 long terminal repeats | Q36554035 |
| | Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells | Q36598618 |
| | Macrophages sustain HIV replication in vivo independently of T cells | Q36737917 |
| | Targeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins | Q36759698 |
| | Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation | Q36796554 |
| | The meningeal lymphatic system: a route for HIV brain migration? | Q36906028 |
| | High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects. | Q37123276 |
| | Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study | Q37413059 |
| | A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy | Q37604524 |
| | A highly reproducible quantitative viral outgrowth assay for the measurement of the replication-competent latent HIV-1 reservoir | Q37663180 |
| | New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo. | Q37695001 |
| | HIV-1 latency in monocytes/macrophages | Q38206643 |
| | Valproic acid perturbs hematopoietic homeostasis by inhibition of erythroid differentiation and activation of the myelo-monocytic pathway | Q38504203 |
| | Reversal of T-cell exhaustion as a strategy to improve immune control of HIV-1. | Q38584018 |
| | Brain Microglial Cells Are Highly Susceptible to HIV-1 Infection and Spread | Q38795540 |
| | Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy | Q38826536 |
| | Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells | Q38924992 |
| | Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy | Q39685944 |
| | Pneumococcal capsular polysaccharide is immunogenic when present on the surface of macrophages and dendritic cells: TLR4 signaling induced by a conjugate vaccine or by lipopolysaccharide is conducive. | Q40016407 |
| | Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir | Q40082046 |
| | HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy | Q40240401 |
| | Macrophage Death following Influenza Vaccination Initiates the Inflammatory Response that Promotes Dendritic Cell Function in the Draining Lymph Node. | Q40302209 |
| | Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy | Q40507703 |
| | PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals | Q40653907 |
| | Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques | Q40734962 |
| | Activation of latent human immunodeficiency virus by the histone deacetylase inhibitor panobinostat: a pilot study to assess effects on the central nervous system | Q40889762 |
| | Alpha E beta 7 and alpha 4 beta 7 integrins associated with intraepithelial and mucosal homing, are expressed on macrophages | Q41371628 |
| | Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects | Q41750120 |
| | Macrophage-derived simian immunodeficiency virus exhibits enhanced infectivity by comparison with T-cell-derived virus | Q41914053 |
| | HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim. | Q41921236 |
| | The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time | Q41954397 |
| | Simian immunodeficiency virus infection of macaque bone marrow macrophages correlates with disease progression in vivo | Q41981904 |
| | A CD3/CD28 microbead-based HIV-1 viral outgrowth assay | Q42365535 |
| | In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment. | Q42381408 |
| | Macrophages are the major target cell for HIV infection in long-term marrow culture and demonstrate dual susceptibility to lymphocytotropic and monocytotropic strains of HIV-1. | Q42628713 |
| | A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy | Q44165805 |
| | Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. | Q45285591 |
| | HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. | Q45954015 |
| | Fc receptor but not complement binding is important in antibody protection against HIV. | Q46545827 |
| | CD14 expression by activated parenchymal microglia/macrophages and infiltrating monocytes following human traumatic brain injury | Q48605136 |
| | Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. | Q52021616 |
| | Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation. | Q52568482 |
| | Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients with Non-Small-Cell Lung Cancer. | Q52598575 |
| | Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30. | Q52731001 |
| | CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacy. | Q52731744 |
| | Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system. | Q53693959 |
| | CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. | Q53822439 |
| | Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals | Q57042022 |
| | Improved assays to measure and characterize the inducible HIV reservoir | Q57477977 |
| | The CD16+ Monocyte Subset Is More Permissive to Infection and Preferentially Harbors HIV-1 In Vivo | Q58003915 |
| P433 | issue | 2 | |
| P304 | page(s) | 129-140 | |
| P577 | publication date | 2019-04-01 | |
| P1433 | published in | Current HIV/AIDS reports | Q26842190 |
| P1476 | title | Impact of Myeloid Reservoirs in HIV Cure Trials | |
| P478 | volume | 16 | |